ICU Medical, Inc. (ICUI) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 1 Strong Buy, 8 Buy, 2 Hold.
The consensus price target is $179.00 (low: $178.00, high: $180.00), representing an upside of 40% from the current price $127.85.
Analysts estimate Earnings Per Share (EPS) of $5.61 and revenue of $2.32B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-4.83 vs est $5.61 (missed -186.1%). 2025: actual $0.03 vs est $7.57 (missed -99.6%). Analyst accuracy: 0%.
ICUI Stock — 12-Month Price Forecast
$179.00
▲ +40.01% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for ICU Medical, Inc., the average price target is $179.00, with a high forecast of $180.00, and a low forecast of $178.00.
The average price target represents a +40.01% change from the last price of $127.85.
Highest Price Target
$180.00
Average Price Target
$179.00
Lowest Price Target
$178.00
ICUI Analyst Ratings
Buy
Based on 11 analysts giving stock ratings to ICU Medical, Inc. in the past 3 months
EPS Estimates — ICUI
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$4.83
vs Est $5.61
▼ 216.1% off
2025
Actual $0.03
vs Est $7.57
▼ 25,393.8% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — ICUI
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $2.382B
vs Est $2.318B
▲ 2.7% off
2025
Actual $2.230B
vs Est $2.206B
▲ 1.1% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
